Search Results
Search for other papers by Lisette van Alewijk in
Google Scholar
PubMed
Search for other papers by Kirsten Davidse in
Google Scholar
PubMed
Search for other papers by Karlijn Pellikaan in
Google Scholar
PubMed
Search for other papers by Judith van Eck in
Google Scholar
PubMed
Academic Centre for Growth, Erasmus University Medical Centre, Rotterdam, the Netherlands
Dutch Growth Research Foundation, Rotterdam, the Netherlands
Search for other papers by Anita C S Hokken-Koelega in
Google Scholar
PubMed
Diabeter, National Diabetes Care and Research Centre, Rotterdam, the Netherlands
Search for other papers by Theo C J Sas in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Leiden University Medical Centre, Leiden, the Netherlands
Search for other papers by Sabine Hannema in
Google Scholar
PubMed
Search for other papers by Aart J van der Lely in
Google Scholar
PubMed
Academic Centre for Growth, Erasmus University Medical Centre, Rotterdam, the Netherlands
Search for other papers by Laura C G de Graaff in
Google Scholar
PubMed
CLS Donohoe ME Brooke AM Mosaic Turner syndrome shows reduced penetrance in an adult population study . Genetics in Medicine 2019 21 877 – 886 . ( https://doi.org/10.1038/s41436-018-0271-6 ) 45 Baker VL Primary ovarian insufficiency in
School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, Sichuan, China
Search for other papers by Xinyuan Zhang in
Google Scholar
PubMed
Search for other papers by Suiyan Li in
Google Scholar
PubMed
Search for other papers by Hongwei Liu in
Google Scholar
PubMed
Search for other papers by Huai Bai in
Google Scholar
PubMed
Search for other papers by Qingqing Liu in
Google Scholar
PubMed
Search for other papers by Chunyi Yang in
Google Scholar
PubMed
Search for other papers by Ping Fan in
Google Scholar
PubMed
, thyroid disorders, hypogonadotropic hypogonadism, hyperprolactinemia, malignancies, premature ovarian insufficiency, or endometriosis were excluded. To determine the genetic links between HMOX2 genetic variants and the risk of PCOS, 1014 patients with
Search for other papers by Caroline Culen in
Google Scholar
PubMed
Search for other papers by Diana-Alexandra Ertl in
Google Scholar
PubMed
Search for other papers by Katharina Schubert in
Google Scholar
PubMed
Search for other papers by Lisa Bartha-Doering in
Google Scholar
PubMed
Search for other papers by Gabriele Haeusler in
Google Scholar
PubMed
latest during early adolescence. Full information about the biological background of ovarian insufficiency in TS should be given again to the parents and in an age-appropriate manner to the girl. Progress in education and vocational planning are
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by M Guftar Shaikh in
Google Scholar
PubMed
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
Search for other papers by Timothy G Barrett in
Google Scholar
PubMed
Search for other papers by Nicola Bridges in
Google Scholar
PubMed
Search for other papers by Robin Chung in
Google Scholar
PubMed
Centre for Endocrinology, William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, UK
Search for other papers by Evelien F Gevers in
Google Scholar
PubMed
Department of Endocrinology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK
Search for other papers by Anthony P Goldstone in
Google Scholar
PubMed
Search for other papers by Anthony Holland in
Google Scholar
PubMed
Search for other papers by Shankar Kanumakala in
Google Scholar
PubMed
Search for other papers by Ruth Krone in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Makarios Children's Hospital, Nicosia, Cyprus
Search for other papers by Andreas Kyriakou in
Google Scholar
PubMed
Sussex Community NHS Trust, Brighton, UK
Search for other papers by E Anne Livesey in
Google Scholar
PubMed
Developmental Endocrinology Research Group, University of Glasgow, Glasgow, UK
Search for other papers by Angela K Lucas-Herald in
Google Scholar
PubMed
Search for other papers by Christina Meade in
Google Scholar
PubMed
Search for other papers by Susan Passmore in
Google Scholar
PubMed
The University of Dublin, Trinity College Dublin, Dublin, Republic of Ireland
Search for other papers by Edna Roche in
Google Scholar
PubMed
Search for other papers by Chris Smith in
Google Scholar
PubMed
Search for other papers by Sarita Soni in
Google Scholar
PubMed
tolerated. The BSPED protocol for pubertal induction in primary ovarian insufficiency using patches can be used ( 127 ). The pubertal stage attained will determine which step in the pubertal induction scheme should be commenced initially. When withdrawal
Department of Endocrinology, St James’s Hospital, Dublin, Ireland
Search for other papers by Agnieszka Pazderska in
Google Scholar
PubMed
Search for other papers by Yaasir Mamoojee in
Google Scholar
PubMed
Search for other papers by Satish Artham in
Google Scholar
PubMed
Search for other papers by Margaret Miller in
Google Scholar
PubMed
Department of Endocrinology, University of Manchester, Manchester, UK
Search for other papers by Stephen G Ball in
Google Scholar
PubMed
Department of Paediatric Endocrinology & Diabetes, Newcastle-upon-Tyne Hospitals, Newcastle upon Tyne, UK
Search for other papers by Tim Cheetham in
Google Scholar
PubMed
Endocrine Research Group, Institute of Genetic Medicine, University of Newcastle-upon-Tyne, Newcastle upon Tyne, UK
Search for other papers by Richard Quinton in
Google Scholar
PubMed
), the proportion of males with congenital hypogonadotrophic hypogonadism (CHH) rises steeply thereafter, eventually comprising the universality of cases by the third decade of life ( 2 ). Whereas both primary and secondary (CHH) ovarian insufficiencies
Search for other papers by Giuseppe Grande in
Google Scholar
PubMed
Search for other papers by Andrea Graziani in
Google Scholar
PubMed
Search for other papers by Antonella Di Mambro in
Google Scholar
PubMed
Search for other papers by Riccardo Selice in
Google Scholar
PubMed
Department of Medicine, University of Padova, Padova, Italy
Search for other papers by Alberto Ferlin in
Google Scholar
PubMed
mineral density and lean mass in young women with premature ovarian insufficiency are prevented by oestrogen replacement . Frontiers in Endocrinology 2022 13 860853 . ( https://doi.org/10.3389/fendo.2022.860853 ) 107 Hosseini SA Cumming RG Bijani
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Alexandra Kulle in
Google Scholar
PubMed
Search for other papers by Juliane Rothermel in
Google Scholar
PubMed
Search for other papers by Caroline Knop-Schmenn in
Google Scholar
PubMed
Search for other papers by Nina Lass in
Google Scholar
PubMed
Search for other papers by Christina Bosse in
Google Scholar
PubMed
Search for other papers by Paul-Martin Holterhus in
Google Scholar
PubMed
Introduction Polycystic ovarian syndrome (PCOS) is a heterogeneous syndrome that is characterized by features of anovulation (amenorrhea and oligomenorrhea) combined with symptoms of androgen excess (hirsutism, acne and alopecia) ( 1 ). The
Search for other papers by Violeta Iotova in
Google Scholar
PubMed
Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed
Search for other papers by Charlotte Van Beuzekom in
Google Scholar
PubMed
Search for other papers by Petra Bruegmann in
Google Scholar
PubMed
Search for other papers by Manuela Broesamle in
Google Scholar
PubMed
Search for other papers by Olaf Hiort in
Google Scholar
PubMed
Search for other papers by Alberto M Pereira in
Google Scholar
PubMed
://endo-ern.eu/events/webinars/ ; Supplementary Fig. 1) was followed by a specific webinar on ‘Update on the Management of 46,XX Ovarian Dysgenesis and Primary Ovarian Insufficiency’ in 1 year. As explained earlier, integrated statistics was not possible throughout the assessed period
Search for other papers by Rebeca Esquivel-Zuniga in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
disease, anorexia nervosa, excessive exercise, chronic kidney disease, sickle cell disease and thalassemia, severe obesity, opioids); chronic stress Female Turner syndrome Premature ovarian insufficiency Kallmann syndrome Combined pituitary
Search for other papers by Elin Kahlert in
Google Scholar
PubMed
Endokrinologikum Goettingen, Goettingen, Germany
Search for other papers by Martina Blaschke in
Google Scholar
PubMed
Search for other papers by Knut Brockmann in
Google Scholar
PubMed
Search for other papers by Clemens Freiberg in
Google Scholar
PubMed
Search for other papers by Onno E Janssen in
Google Scholar
PubMed
Search for other papers by Nikolaus Stahnke in
Google Scholar
PubMed
Search for other papers by Domenika Strik in
Google Scholar
PubMed
Search for other papers by Martin Merkel in
Google Scholar
PubMed
Search for other papers by Alexander Mann in
Google Scholar
PubMed
Search for other papers by Klaus-Peter Liesenkötter in
Google Scholar
PubMed
Endokrinologikum Goettingen, Goettingen, Germany
Search for other papers by Heide Siggelkow in
Google Scholar
PubMed
estrogen replacement therapy to treat ovarian insufficiency and induce puberty. Although human growth hormone therapy (hGHT) has been established in TS patients, its efficacy varies and depends on many factors, including dose, duration, and age at treatment